1 |
|
|
Condition: |
|
Acromegaly |
Intervention: |
|
|
|
2 |
|
|
Condition: |
|
HIV Infections |
Interventions: |
|
Behavioral: Affect Management; Behavioral: General Health Promotion |
|
3 |
|
|
Condition: |
|
Infertility |
Interventions: |
|
Drug: human chorionic gonadotropin; Drug: recombinant gonadotropins |
|
4 |
|
|
Condition: |
|
Non-Prescription |
Intervention: |
|
Drug: Naproxen Sodium ER |
|
5 |
|
|
Condition: |
|
Respiratory Cancer |
Interventions: |
|
Other: Control group; Other: Conventional resistance training; Other: Whole body vibration resistance training |
|
6 |
|
|
Condition: |
|
Amyotrophic Lateral Sclerosis |
Intervention: |
|
Drug: SB-509 |
|
7 |
|
|
Condition: |
|
Contraception |
Intervention: |
|
Drug: Norgestimate/ethinyl estradiol; Drospirenone/ethinyl estradiol |
|
8 |
|
|
Condition: |
|
Hyperlipidemia |
Intervention: |
|
Drug: Nattokinase |
|
9 |
|
|
Condition: |
|
Bipolar Disorder |
Interventions: |
|
Behavioral: Replicating Effective Programs Framework for the Bipolar Care Model; Behavioral: Bipolar Care Model Package Only |
|
10 |
|
|
Conditions: |
|
Breast Cancer; Chemotherapeutic Agent Toxicity; Palmar-Plantar Erythrodysesthesia |
Intervention: |
|
Drug: nicotine |
|
11 |
|
|
Conditions: |
|
Kidney Transplantation; Vitamin D Deficiency; Renal Osteodystrophy |
Interventions: |
|
Drug: Cholecalciferol; Drug: Placebo |
|
12 |
|
|
Condition: |
|
Hereditary Angioedema |
Intervention: |
|
Drug: C1-Esterase Inhibitor |
|
13 |
|
|
Condition: |
|
Refractory Hypertension |
Intervention: |
|
Device: nCPAP |
|
14 |
|
|
Condition: |
|
Solid Tumors and Ovarian Neoplasms |
Intervention: |
|
Drug: Comparator: MK4827 |
|
15 |
|
|
Condition: |
|
Healthy Volunteer |
Interventions: |
|
Drug: AZD6280; Drug: AZD6280; Drug: Lorazepam; Drug: Placebo |
|
16 |
|
|
Conditions: |
|
Chronic Kidney Disease; Vitamin D; Coronary Calcification; Bone Metabolism |
Interventions: |
|
Drug: Calcitriol (Rocaltrol®); Drug: Paricalcitol |
|
17 |
|
|
Condition: |
|
Carotid Artery Disease |
Intervention: |
|
Drug: Simvastatin |
|
18 |
|
|
Condition: |
|
Healthy Subjects |
Intervention: |
|
Procedure: Tai Chi Cuan |
|
19 |
|
|
Condition: |
|
Non-Melanomatous Skin Cancer |
Intervention: |
|
Drug: aminolevulinic acid |
|
20 |
|
|
Condition: |
|
Stress Disorders, Post-Traumatic |
Interventions: |
|
Drug: Midazolam; Drug: Ketamine |
|
21 |
|
|
Conditions: |
|
Tobacco Cessation; Oral Cancer |
Intervention: |
|
Behavioral: Behavioural and Pharmacotherapy for tobacco cessation |
|
22 |
|
|
Conditions: |
|
Liver Cirrhosis; Renal Failure |
Interventions: |
|
Drug: Rifaximin; Drug: Lactulose |
|
23 |
|
|
Condition: |
|
Severe Primary IGFD |
Intervention: |
|
Biological: mecasermin [rDNA origin] injection |
|
24 |
|
|
Condition: |
|
Renal Failure |
Interventions: |
|
Procedure: Dialysis during 4 hours; Procedure: Dialysis during 6 hours; Procedure: Dialysis during 8 hours |
|
25 |
|
|
Condition: |
|
Psychotic Depression |
Intervention: |
|
Drug: Quetiapine |
|
26 |
|
|
Conditions: |
|
Acute Lung Injury; Acute Respiratory Distress Syndrome; Mechanical Ventilation |
Interventions: |
|
Device: APRV; Device: Conventional MV |
|
27 |
|
|
Condition: |
|
Colon Preparation |
Interventions: |
|
Other: low fiber diet; Other: regular diet |
|
28 |
|
|
Condition: |
|
Kidney Cancer |
Interventions: |
|
Drug: sunitinib malate; Procedure: adjuvant therapy; Procedure: gene expression analysis; Procedure: immunohistochemistry staining method; Procedure: laboratory biomarker analysis; Procedure: neoadjuvant therapy; Procedure: reverse transcriptase-polymerase chain reaction; Procedure: therapeutic conventional surgery; Procedure: western blotting |
|
29 |
|
|
Condition: |
|
Fibromyalgia |
Interventions: |
|
Drug: Esreboxetine; Drug: Esreboxetine |
|
30 |
|
|
Condition: |
|
Obesity |
Interventions: |
|
Drug: Placebo; Drug: Placebo + S-2367 (velneperit); Drug: S-2367 (velneperit) |
|
31 |
|
|
Conditions: |
|
Prostate Cancer; Ovarian Cancer |
Interventions: |
|
Drug: Sagopilone 16 mg/m2 i.v. and Acetyl-L-Carnitine (ALC) 1000 mg tid; Drug: Sagopilone 16 mg/m2 i.v. and placebo 1000 mg tid |
|
32 |
|
|
Condition: |
|
Atrial Fibrillation |
Intervention: |
|
Device: Implantable Loop Recorder (ILR) |
|
33 |
|
|
Condition: |
|
Obesity |
Interventions: |
|
Behavioral: Individual telephone intervention; Behavioral: Group telephone intervention |
|
34 |
|
|
Conditions: |
|
Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1 |
Intervention: |
|
Drug: Techonosphere Insulin Inhalation Powder |
|
35 |
|
|
Condition: |
|
Depression |
Intervention: |
|
|
|
36 |
|
|
Condition: |
|
Asthma |
Intervention: |
|
Drug: GSK2190915 |
|
37 |
|
|
Condition: |
|
Osteosarcoma |
Interventions: |
|
Drug: AZD0530; Drug: Placebo |
|
38 |
|
|
Condition: |
|
Perineal Tear Grade 1 After Vaginal Delivery |
Interventions: |
|
Device: 1. Dermabond Topical Skin Adhesive 2-Octyl Cyanoacrylate; Device: 2. Histoacryl n-Butyl-2 Cyanoacrylate; Procedure: 3. traditional suturing with vicryl rapid 2X0 |
|
39 |
|
|
Condition: |
|
Hypertriglyceridemia |
Intervention: |
|
Drug: fenofibrate |
|
40 |
|
|
Condition: |
|
Down Syndrome |
Intervention: |
|
Drug: Rivastigmine |
|
41 |
|
|
Conditions: |
|
Death, Sudden, Cardiac; Arrhythmias, Cardiac |
Interventions: |
|
Dietary Supplement: Docosahexaenoic acid (DHA); Dietary Supplement: Placebo |
|
42 |
|
|
Condition: |
|
Alzheimer's Disease |
Interventions: |
|
Drug: atorvastatin; Drug: Placebo |
|
43 |
|
|
Condition: |
|
Sleep Apnea, Obstructive |
Intervention: |
|
Device: Slow Titration Device |
|
44 |
|
|
Condition: |
|
Postmenopausal Women |
Interventions: |
|
Drug: tibolone; Drug: Tibolone 2.5 mg; Drug: CE/MPA |
|
45 |
|
|
Conditions: |
|
Cerebral Palsy; Prematurity |
Intervention: |
|
|
|
46 |
|
|
Condition: |
|
Chronic Ischaemic Heart Failure |
Interventions: |
|
Drug: Granulocyte-colony stimulating factor; Procedure: Percutaneous intracoronary injection; Procedure: Percutaneous intramyocardial injection |
|
47 |
|
|
Condition: |
|
Familial Hypercholesterolemia |
Interventions: |
|
Drug: APL180; Drug: APL180; Drug: Placebo |
|
48 |
|
|
Condition: |
|
Metabolic Syndrome |
Interventions: |
|
Drug: Ramipril and placebo; Drug: Tadalafil and placebo; Drug: placebo and placebo; Drug: tadalafil and ramipril |
|
49 |
|
|
Condition: |
|
Headache |
Intervention: |
|
Other: Expert system guided tailored information |
|
50 |
|
|
Conditions: |
|
Abscess; Skin Diseases, Infectious; Boils; Furuncle; Carbuncle; Folliculitis; Cellulitis; Wound |
Interventions: |
|
Procedure: Wound packing; Procedure: NoPacking |
|